SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/CFDC211FC19247E7E4C43BF39706842F12A6041CFD255613402CDED11E7837B038D54FCB6DE268DC1D5F99021F6CA989>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/CFDC211FC19247E7E4C43BF39706842F12A6041CFD255613402CDED11E7837B038D54FCB6DE268DC1D5F99021F6CA989
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/CFDC211FC19247E7E4C43BF39706842F12A6041CFD255613402CDED11E7837B038D54FCB6DE268DC1D5F99021F6CA989
http://www.w3.org/2000/01/rdf-schema#comment
"In conclusion SPRY2 is an important tumour suppressor in prostate cancer since its loss drives the PI3K/AKT pathway via functional interaction with the ErbB system."
xsd:string
http://purl.uniprot.org/uniprot/#_4E58C31F2BDE190A17176323AFA88737940D71B61144AE42627F56B3C33D111F834EE376F5E96F5FA756D37B972DF512
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/CFDC211FC19247E7E4C43BF39706842F12A6041CFD255613402CDED11E7837B038D54FCB6DE268DC1D5F99021F6CA989
http://purl.uniprot.org/uniprot/Q7Z783
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CFDC211FC19247E7E4C43BF39706842F12A6041CFD255613402CDED11E7837B038D54FCB6DE268DC1D5F99021F6CA989
http://purl.uniprot.org/uniprot/#_Q7Z783-mappedCitation-22649008
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/CFDC211FC19247E7E4C43BF39706842F12A6041CFD255613402CDED11E7837B038D54FCB6DE268DC1D5F99021F6CA989